Technical Analysis for LNTH - Lantheus Holdings, Inc.

Grade Last Price % Change Price Change
grade C 24.62 2.46% 0.59
LNTH closed up 2.46 percent on Friday, September 13, 2019, on 72 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical LNTH trend table...

Date Alert Name Type % Chg
Crossed Above 50 DMA Bullish 0.00%
Upper Bollinger Band Walk Strength 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.46%
Pocket Pivot Bullish Swing Setup 2.46%
Stochastic Reached Overbought Strength 2.46%

Older signals for LNTH ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Lantheus Holdings, Inc. is engaged in developing, manufacturing, selling and distributing diagnostic medical imaging agents and products that assist clinicians in the diagnosis of cardiovascular and other diseases. The Company's medical imaging agents are used to diagnose coronary artery disease, congestive heart failure, stroke, peripheral vascular disease and other diseases. The Company's products include contrast agents and medical radiopharmaceuticals, including technetium generators. The Company's products include DEFINITY, TechneLite, Xenon Xe 133 Gas, Cardiolite, Neurolite, Thallium Tl 201, Gallium Ga 67, Gludef, Quadramet and Ablavar. The Company is also engaged in developing agents, such as Flurpiridaz F 18, which is a myocardial perfusion imaging agent; 18F LMI 1195, which is a cardiac neuronal imaging agent, and LMI 1174, which is a vascular remodeling imaging agent.
Medicine Chemistry Diseases Chemical Elements Medical Imaging Medical Physics Coronary Artery Disease Peripheral Vascular Disease Stroke Medicinal Radiochemistry Radiopharmaceuticals Congestive Heart Failure Cardiovascular And Other Diseases F 18
Is LNTH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 29.8
52 Week Low 12.59
Average Volume 363,063
200-Day Moving Average 22.4595
50-Day Moving Average 24.1182
20-Day Moving Average 22.553
10-Day Moving Average 22.54
Average True Range 0.9562
ADX 23.32
+DI 27.188
-DI 23.764
Chandelier Exit (Long, 3 ATRs ) 21.8814
Chandelier Exit (Short, 3 ATRs ) 23.1986
Upper Bollinger Band 24.4131
Lower Bollinger Band 20.6929
Percent B (%b) 1.06
BandWidth 16.495366
MACD Line -0.038
MACD Signal Line -0.4558
MACD Histogram 0.4178
Fundamentals Value
Market Cap 919.55 Million
Num Shares 37.3 Million
EPS 0.73
Price-to-Earnings (P/E) Ratio 33.73
Price-to-Sales 2.17
Price-to-Book 0.00
PEG Ratio 0.69
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.58
Resistance 3 (R3) 25.52 25.13 25.42
Resistance 2 (R2) 25.13 24.89 25.17 25.37
Resistance 1 (R1) 24.88 24.74 25.01 24.94 25.31
Pivot Point 24.49 24.49 24.56 24.53 24.49
Support 1 (S1) 24.24 24.25 24.37 24.30 23.93
Support 2 (S2) 23.85 24.10 23.89 23.87
Support 3 (S3) 23.60 23.85 23.82
Support 4 (S4) 23.66